# Cardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR‐DM‐HF)

**Authors:** Joanna Osmanska, Kieran F. Docherty, Colin Berry, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Giles Roditi, Naveed Sattar, Mark C. Petrie, Ross T. Campbell, Matthew M.Y. Lee

PMC · DOI: 10.1002/ejhf.3570 · 2025-01-10

## Full-text entities

- **Diseases:** heart failure (MESH:D006333), congestion (MESH:D002311), type 2 diabetes (MESH:D003924), reduced (MESH:D001523), DM (MESH:D009223), diabetes (MESH:D003920)
- **Chemicals:** empagliflozin (MESH:C570240)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12765038/full.md

---
Source: https://tomesphere.com/paper/PMC12765038